Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Caserta
Clinical trial register · Italy

Clinical Trials in Caserta, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6778 matching records held by the registry are in this view. Synced 08 Oct 2026, 03:19 UTC
6778
Studies in scope
all four open statuses
4069
Recruiting now
open to new participants
1018
Lead sponsors
across recruiting studies
Top sites
Milan 2843 Bologna 1305 Roma 1274 Naples 984 Rome 967
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna3 Heart Care Foundation3 Novartis Pharmaceuticals3 Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi)2 National Cancer Institute, Naples2
Site location
Milan2843 Bologna1305 Roma1274 Naples984 Rome967
All 489 locations
Target enrolment
to

Trials with a site in Caserta

49 of 6778 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Not yet open
Heart Care Foundation
Phase 3
600
Acquaviva delle Fonti, Altamura, Arezzo, Avellino, Bari, Casale Monferrato, Caserta, Catania
2026-09
Recruiting
Chiesi Italia
Observational
75
Arezzo, Bari, Bologna, Caserta, Monza, Naples, Palermo
2026-06-15
Not yet open
Standardized Italian netwoRk Enrolling iNdividuals With Islet-Autoantibodies
NCT07503366Type 1 Diabetes (T1D), Autoantibodies, Hyperglycemia, Impaired Glucose Tolerance (Prediabetes)
Società Italiana di Endocrinologia e Diabetologia Pediatrica
Observational
300
Ancona, Bari, Bolzano, Caserta, Catanzaro, Crotone, Florence, L’Aquila
2026-05
Recruiting
Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi)
Observational
52
Caserta, Catania, Cinisello Balsamo, Florence, Naples, Padova, Palermo, Roma
2026-04-30
Recruiting
Gruppo Oncologico Italia Meridionale
Phase 2
150
Alessandria, Ancona, Aviano, Caserta, Castellana Grotte, Catania, Catanzaro, Florence
2026-03-20
Recruiting
Prilenia
Phase 3
500
Caserta, Milan, Modena, Padova, Torino
2026-02-01
Recruiting
UNICANCER
Phase 3
3,902
Aviano, Caserta, Genova, Naples, Padova, Pisa, Pontedera, Roma
2025-12-18
Not yet open
Heart Care Foundation
Not applicable
240
Orbassano, Torino, Acquaviva delle Fonti, Ancona, Arzignano, Benevento, Cagliari, Caserta
2025-12-11
Recruiting
Pfizer
Phase 3
680
Aviano, Rome, Roma, Florence, Verona, Bergamo, Caserta, Genova
2025-09-29
Recruiting
Federico II University
Phase 4
80
Caserta, Naples
2025-09-08
Recruiting
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
NCT07157774Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD)
Eli Lilly and Company
Phase 3
10,450
Arzignano, Baggiovara, Bologna, Caserta, Ferrara, Ferrara (Cona), Florence, Genova
2025-09-02
Recruiting
Focused Orticumab Research for Treating Inflammation in Coronary Arteries
NCT06927739Acute Coronary Syndromes, Coronary Arterial Disease (CAD), Inflammation, Heart Disease
Abcentra
Phase 2
240
Caserta, Ferrara, Brescia, Milan, Pavia
2025-08-11
Recruiting
Amgen
Phase 3
12,800
Arzignano, Caserta, Ceccano, Chieti, Foggia, L’Aquila, Milan, Padova
2025-07-25
Recruiting
Long-term Characterization of GORE® TAG® Conformable Thoracic Stent Graft With ACTIVE CONTROL System Performance
NCT06658730Vascular Disease, Dissection, Dissection Aortic Aneurysm, Dissection of Aorta
W.L.Gore & Associates
Observational
1,500
Caserta, Milan
2025-06-19
Recruiting
AstraZeneca
Phase 3
15,100
Altamura, Arzignano, Bergamo, Bologna, Brescia, Caserta, Catania, Cona
2025-06-04
Active, closed
Novartis Pharmaceuticals
Phase 3
246
Ancona, Caserta, Grosseto, Milan, Rozzano, Perugia, Pordenone, Salerno
2025-04-30
Recruiting
Microplastics and Nanoplastics (MNPs) in Patients With ST-elevation Myocardial Infarction (STEMI)
NCT06965023ST-elevation Myocardial Infarction (STEMI), Microplastics, Nanoplastics, Pollution Exposure
Azienda Ospedaliera "Sant'Andrea"
Observational
130
Roma, Caserta, Catania, Ferrara, Forlì, Milan, Naples, Turin
2025-04-22
Recruiting
Hoffmann-La Roche
Phase 3
450
Tricase (LE), Caserta, Naples, Bologna, Meldola, Modena, Rome, Bergamo
2025-04-09
Recruiting
National Cancer Institute, Naples
Phase 2
130
Caserta, Naples, Avellino, Udine, Tricase, Frattamaggiore, Pozzuoli
2025-03-12
Not yet open
Consorzio Oncotech
Observational
1,000
Avellino, Bergamo, Bologna, Brescia, Termoli, Caserta, Cuneo, Ferrara
2025-03
Active, closed
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
2,000
Acquaviva delle Fonti, Ancona, Avellino, Bari, Bolzano, Brescia, Casale Monferrato, Caserta
2025-02-12
Recruiting
Microplastics and Nanoplastics in Patients With Chronic Coronary Syndromes
NCT07291609Chronic Coronary Syndrome, Microplastics, Nanoplastics, Coronary Artery Disease
Azienda Ospedaliera "Sant'Andrea"
Observational
120
Caserta, Forlì, Milan, Naples, Roma, Verona
2025-01-01
Active, closed
DJO UK Ltd
Not applicable
64
Caserta, Milan, Roma
2024-11-23
Recruiting
Shanghai Henlius Biotech
Phase 3
550
Caserta, Cremona, Naples, Rozzano, San Giovanni Rotondo, Torrette, Udine
2024-11-22
Recruiting
A Multifocal tDCS-EEG Protocol for Improving Symptoms of Mild Cognitive Impairment and Early Dementia
NCT06668610Mild Cognitive Impairment (MCI), Dementia, Alzheimer Disease, Early Onset, Alzheimer Disease
University of Campania Luigi Vanvitelli
Not applicable
50
Caserta
2024-10-01
Recruiting
Prevention ICONA Dedicated Ensemble
NCT07186244PrEP, PrEP Adherence Monitoring, HIV, HIV -1 Infection
Fondazione ICONA
Observational
5,000
Chieti, Pescara, Bari, Foggia, Potenza, Caserta, Naples, Bologna
2024-09-09
Active, closed
Evaluation of the Effect of Lomitapide Treatment on Major Adverse Cardiovascular Events (MACE) in Patients With Homozygous Familial Hypercholesterolemia
NCT06832371Homozygous Familial Hypercholesterolemia (HoFH), Major Adverse Cardiovascular Events (MACE), Dyslipidemia
Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi)
Observational
73
Catanzaro, Caserta, Naples, Bologna, Ferrara, Modena, Genova, Catania
2024-09-09
Recruiting
Fondazione Oncotech
Observational
300
Avellino, Ancona, Aviano, Bari, Barletta, Bergamo, Caserta, Genova
2024-07-01
Active, closed
Novo Nordisk A/S
Phase 3
10,000
Chieti, Caserta, Cona (Ferrara), Latina, Bergamo, San Donato Milanese, Turin, Pordenone
2024-06-25
Recruiting
Centro di Riferimento Oncologico - Aviano
Observational
1,000
Aviano, Caserta, Naples, Trieste
2024-05-13
Recruiting
CSL Behring
Phase 2/3
3,110
Bologna, Brescia, Cagliari, Caserta, Catania, Ferrara, Florence, Foggia
2024-04-27
Recruiting
Integrated Approach in Frail Older People with Atrial Fibrillation
NCT06775028Atrial Fibrillation (AF), Hypertension, Coronary Arterial Disease (CAD), Heart Failure
Heart Care Foundation
Not applicable
1,250
Caserta, Florence, Genova, Grosseto, Monza, Milan, Piacenza, Gubbio
2024-04-11
Recruiting
Novartis Pharmaceuticals
Phase 2
502
Ancona, Bergamo, Bologna, Brescia, Caserta, Cona, Pozzilli, Milan
2024-03-07
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
96
Bologna, Caserta, Catania, Ferrara, Florence, Milan, Novara, Palermo
2024-03-01
Recruiting
The ONCOCAMP Study
NCT06270602Oncology
National Cancer Institute, Naples
Observational
15,000
Avellino, Benevento, Caserta, Casavatore, Ercolano, Naples, Salerno
2023-07-14
Recruiting
Hoffmann-La Roche
Phase 3
420
Caserta, Meldola, Ravenna, Aviano, Milan, Alessandria, Turin, Misterbianco (CT)
2023-06-07
Active, closed
Janssen Research & Development, LLC
Phase 3
20,284
Arezzo, Aversa, Bergamo, Bologna, Caserta, Catania, Catanzaro, Ferrara
2023-04-11
Active, closed
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
NCT05739383Primary Prevention of Atherosclerotic Cardiovascular Disease
DrugInclisiran
Novartis Pharmaceuticals
Phase 3
14,012
Ancona, Brescia, Caserta, Chieti, Catanzaro, Florence, Chiavari, Genova
2023-03-09
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
65
Bologna, Caserta, Bari, Ferrara, Florence, Milan, Novara, Padova
2023-03-01
Recruiting
Anthos Therapeutics, Inc.
Phase 3
2,500
Ancona, Bologna, Brescia, Cagliari, Caserta, Catanzaro, Cinisello Balsamo, Florence
2022-12-27
Active, closed
Amgen
Phase 3
7,297
Arzignano, Bologna, Brescia, Caserta, Catania, Catanzaro, Cona FE, Florence
2022-12-14
Active, closed
Ionis Pharmaceuticals, Inc.
Phase 3
885
Bergamo, Bologna, Caserta, Milan, Naples, Palmero, Rome
2022-12-13
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
800
Chieti, Potenza, Caserta, Catanzaro, Cosenza, Bologna, Genova, Bergamo
2022-01-26
By invitation
Viatris Innovation GmbH
Phase 3
25,000
Arezzo, Bologna, Caserta, Catania, Catanzaro, Cona, Florence, Messina
2021-08-14
Recruiting
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 3
414
Alessandria, Ancona, Ascoli Piceno, Avellino, Bari, Bologna, Caserta, Castelfranco Veneto
2020-09-24
Active, closed
Karyopharm Therapeutics Inc
Phase 2/3
501
Ancona, Caserta, Naples, Novara, Pescara, Rome, Palermo, Turin
2020-09-03
Recruiting
Federico II University
Observational
5,000
Arzignano, Bari, Caserta, Catanzaro, Eboli, Foggia, Genova, Lecce
2020-03-07
Active, closed
Consorzio Futuro in Ricerca
Not applicable
1,445
Bologna, Ferrara, Cotignola, Ravenna, Reggio Emilia, Rimini, Agrigento, Caserta
2019-07-15
Recruiting
Product Surveillance Registry
NCT01524276Cardiac Rhythm Disorders, Urological Disorders, Neurological Disorders, Cardiovascular Disorders
Medtronic
Observational
100,000
Acquaviva delle Fonti, Ancona, Bari, Bologna, Brescia, Caserta, Castrovillari, Cotignola
2012-01
Rows per page Showing 1–49 of 49
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 10 October 2026. https://priyalifescience.com/clinical-trials-italy/city/caserta

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,778 studies in total at the last sync on 08 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 49 of those studies with a site in Caserta.

How many clinical trials are recruiting in Caserta?

33 of the 49 studies on this page are recruiting new participants as of the 08 Oct 2026, 03:19 UTC sync. A further 4 have not yet opened recruitment, 11 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Caserta), 49 studies
PhaseStudiesRecruitingShare
Phase 3191138.8%
Observational181436.7%
Not applicable5210.2%
Phase 2448.2%
Phase 2/3214.1%
Phase 4112%

Most active sponsors

Lead sponsors with the most studies (Caserta)
Lead sponsorStudiesRecruiting
Heart Care Foundation31
IRCCS Azienda Ospedaliero-Universitaria di Bologna33
Novartis Pharmaceuticals31
Amgen21
Azienda Ospedaliera "Sant'Andrea"22
Federico II University22
Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi)21
Hoffmann-La Roche22
National Cancer Institute, Naples22
Abcentra11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.